Sigma Pharmaceuticals, a leading UK wholesaler and distributor, is partnering with logistics technology innovator, BoxxDocks, to enhance efficiency and sustainability within its warehouse and transport operations.
The partnership will see Sigma become the first company in the pharmaceutical industry to leverage BoxxDocks’ advanced tracking technology to improve asset visibility and management.
BoxxDocks’ technology offers data-driven, granular track and trace solutions – the first of its kind in the supply chain and logistics industry. This solution not only addresses the critical issue of inventory loss but also paves the way for cost savings and environmental benefits.
Unlike traditional tracking systems that offer limited visibility, BoxxDocks provides real-time data on asset location and movement, enabling B2B distributors to map their entire supply chains with unprecedented accuracy and efficiency. This capability can significantly enhance operational efficiency and reduce costs by optimising asset utilisation and minimising loss.
In addition, the technology offers enhanced security for items in transit, thereby reducing waste and supporting a circular economy, by facilitating a shift towards reusable assets, instead of single-use cardboard and plastic, lowering both environmental and financial impacts.
Rajiv Shah, Procurement and Innovation Officer at Sigma, commented: “This partnership with BoxxDocks will help accelerate our commitment to sustainability and NHS net zero objectives. By having the ability to track our assets, we’ll be able to minimise our environmental footprint by significantly reducing single-use materials, cutting down on the use of disposable packaging, while streamlining our distribution processes.”
Alessandro Attanzio, CEO of BoxxDocks, said: “Our mission is to help enhance B2B distribution through our smart, sustainable and cost-saving solutions. We’re delighted to be working with Sigma Pharmaceuticals, which is a forward-thinking company with a passion for innovation that rivals our own. We look forward to continuing our journey of innovation together, demonstrating a model of best practice for pharma distribution.”
He added: “Through this collaboration, we have further refined our technology to meet the specific needs of the pharmaceutical sector. It is a shining example of how our technology can transform operations, reduce cost and environmental impact, and help drive the industry forward to meet efficiency and sustainability goals.”
